| 中文名 | 14-去氧-11,12-二去氢穿心莲内酯 |
|---|---|
| 英文名 | 14-Deoxy-11,12-didehydroandrographolide |
| 中文别名 |
雄茸交酯
12-二去氢穿心莲内酯 14一去氧-11,12一二脱氢穿心莲内脂 14-脱水穿心莲内酯 14-去氧-11,12-二去氢androapholide 化合物:14-deoxy-11,12-didehydro Androapholide 化合物:14-deoxy-11,12-didehydro Androapholide 14-去氧-11 14-去氧-11,12-脱氢androapholide 14-脱氧11,14-二脱氢穿心莲内酯 穿心莲内酯杂质1 14-脱氧-11,12-二氢穿心莲内酯 穿心莲内酯14-Deoxy-11,12-didehydroandroapholide 3-((E)-2-((1R,4aS,5R,6R,8-6-羟基-5-(羟甲基)-5,8-二甲基-2-甲基(氢萘-1-基)乙烯基)呋喃-2(5H)-酮 14-脱氧-11,12- 穿心莲内酯 14-脱氧-11,12-二去氢穿心莲内酯,10 MM DMSO 溶液 穿心莲内酯 穿心莲乙素 14-去氧11,12去氧穿心莲内酯 |
| 英文别名 |
14-Deoxy 11,14-didehydroandroapholide-RM
AP 10 14-Deoxy-11,14-didehydroandroapholide 3-{(E)-2-[(1R,4aS,5R,6R,8aR)-6-Hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]vinyl}-2(5H)-furanone 3-[(E)-2-[(1R,4aβ)-2-Methylene-5α-(hydroxymethyl)-6α-hydroxy-5,8aα-dimethyldecahydronaphthalene-1α-yl]ethenyl]-2,5-dihydrofuran-2-one 3,19-Dihydroxylabda-8,11,13-trien-16,15-olide 4-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-2H-furan-5-one 3-[(E)-2-[(1R,4aβ)-2-Methylene-5α-(hydroxymethyl)-5,8aα-dimethyl-6α-hydroxydecalin-1α-yl]ethenyl]-2,5-dihydrofuran-2-one Androapholide Impurity 1 3-[(E)-2-[(1R,4aβ)-Decahydro-6α-hydroxy-5α-(hydroxymethyl)-5,8aα-dimethyl-2-methylenenaphthalen-1-yl]vinyl]furan-2(5H)-one 14-Deoxy-11,12-didehydroandroapholide, 10 mM in DMSO 14-Deoxy-11,12-didehydroandroapholide16,15-olide 14-dehydro Androapholide Deoxy-11,12-Didehydroandroapholide, 14 2(5H)-Furanone, 3-[(1E)-2-[(1R,4aS,5R,6R,8-decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethenyl] 14-deoxy11,12 deoxyandroapholide Deoxy 11,14-didehydroandroapholide ent-(3β,11E)-3,19-Dihydroxy-8,11,13-labdatrien-16,15-olide 14 - deoxy11,dehydroandroapholide 14-DEOXY-11,12-DIDEHYDROANDROAPHOLIDE 11,12-Didehydro-14-deoxyandroapholide 3-[(1E)-2-[(1R,4aS,5R,6R,8-Decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethenyl]- 2(5H)-furanone 14-DEOXY-11,12-DIDEHYDROANDROAPHOLIDE //BP 4-[(E)-2-[(1R,4aS,5R,6R,8-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethenyl]-2H-furan-5-one 3-((E)-2-((1R,4aS,5R,6R,8-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl)vinyl)furan-2(5H)-one 14-Deoxy-11,12-didehydroandroapholide 3-{(E)-2-[(1R,4aS,5R,6R,8aR)-6-Hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl]vinyl}furan-2(5H)-one 14-Deoxy-11,12-didehydroandroaphol |
| 描述 | 14-Deoxy-11,12-didehydroandrographolide 是 Andrographolide 的类似物。14-Deoxy-11,12-didehydroandrographolide 抑制 NF-κB 活化。 |
|---|---|
| 相关类别 | |
| 靶点 |
NF-κB |
| 体外研究 | 14-脱氧-11,12-二脱水穿心莲内酯,一种天然存在的穿心莲内酯的非细胞毒性类似物,有效地减少卵清蛋白(OVA)诱导的炎性细胞募集到支气管肺泡灌洗液(BAL),IL-4,IL-5,IL-13和嗜酸性粒细胞趋化因子的产生,血清IgE合成,肺嗜酸性粒细胞增多,粘液分泌过多,肥大细胞脱颗粒和小鼠哮喘模型的气道高反应性(AHR),可能是通过抑制NF-κB活性[1]。 |
| 体内研究 | 14-脱氧-11,12-二脱水穿心莲内酯(1mg/kg)显着降低OVA攻击的小鼠对乙酰甲胆碱的抗性(R1)和恢复Cdyn [1]。 |
| 细胞实验 | 将A549细胞(3×103 /孔),BEAS-2B细胞(5×103 /孔)和RBL-2H3细胞(3×103 /孔)接种在平底96孔板中过夜,然后孵育增加浓度(3-120μM)的14-脱氧-11,12-二脱水穿心莲内酯或穿心莲内酯在37℃下24和48小时。使用CellTiter 96 AQueous细胞增殖测定分析细胞活力。该MTS测定基于活细胞将可溶性四唑盐转化为有色甲product产物的能力。吸光度记录在490 nm [1]。 |
| 动物实验 | 小鼠[1]将6至8周龄的雌性BALB / c小鼠致敏并用OVA攻击。简而言之,在第0天和第14天,通过腹膜内注射20μgOVA和4mg悬浮在0.1mL盐水中的Al(OH)3致敏小鼠。在第22,23和24天,用1%OVA攻击小鼠。气溶胶30分钟。在每次OVA气溶胶攻击之前2小时和之后10小时通过ip注射给予在0.1mL盐水中的14-脱氧-11,12-二脱水穿心莲内酯(0.1,0.5和1mg / kg)或载体(1%DMSO)。盐水气溶胶用作阴性对照。 |
| 参考文献 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 519.6±50.0 °C at 760 mmHg |
| 熔点 | 204-205ºC |
| 分子式 | C20H28O4 |
| 分子量 | 332.434 |
| 闪点 | 182.4±23.6 °C |
| 精确质量 | 332.198761 |
| PSA | 66.76000 |
| LogP | 1.89 |
| 蒸汽压 | 0.0±3.1 mmHg at 25°C |
| 折射率 | 1.567 |
| 储存条件 | -20°C |
| 危险品运输编码 | NONH for all modes of transport |
|---|
|
~91%
42895-58-9 |
| 文献:Xu, Hai-Wei; Zhang, Jianye; Liu, Hong-Min; Wang, Jun-Feng Synthetic Communications, 2006 , vol. 36, # 4 p. 407 - 414 |
|
~%
42895-58-9 |
| 文献:Matsuda; Kuroyanagi; Sugiyama; Umehara; Ueno; Nishi Chemical and Pharmaceutical Bulletin, 1994 , vol. 42, # 6 p. 1216 - 1225 |
| 上游产品 1 | |
|---|---|
| 下游产品 0 | |